Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
A Phase II Evaluation of Weekly Docetaxel (NSC #628503) in the Treatment of Recurrent or Persistent Endometrial Carcinoma
RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop tumor cells from dividing so they stop growing or die.
PURPOSE: This phase II trial is studying how well docetaxel works in treating patients with recurrent or persistent endometrial carcinoma (cancer).
研究概览
详细说明
OBJECTIVES:
- Determine the antitumor activity of docetaxel in patients with recurrent or persistent endometrial carcinoma.
- Determine the toxicity of this drug in these patients.
OUTLINE: This is a multicenter study.
Patients receive docetaxel IV over 1 hour on days 1, 8, and 15. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Patients are followed every 3 months for 2 years and then every 6 months for 3 years.
PROJECTED ACCRUAL: A total of 19-51 patients will be accrued for this study within 10-18 months.
研究类型
阶段
- 阶段2
联系人和位置
学习地点
-
-
Alberta
-
Calgary、Alberta、加拿大、T2N 4N2
- Tom Baker Cancer Centre - Calgary
-
-
-
-
-
Oslo、挪威、N-0310
- Norwegian Radium Hospital
-
-
-
-
-
Kagoshima City、日本、892-8580
- Kagoshima City Hospital
-
-
-
-
New South Wales
-
Camperdown、New South Wales、澳大利亚、1450
- Australia New Zealand Gynaecological Oncology Trials Group
-
-
-
-
Alabama
-
Birmingham、Alabama、美国、35294-3300
- Comprehensive Cancer Center at University of Alabama at Birmingham
-
-
Arizona
-
Phoenix、Arizona、美国、85006-2726
- CCOP - Western Regional, Arizona
-
-
California
-
Los Angeles、California、美国、90095-1740
- Jonsson Comprehensive Cancer Center at UCLA
-
Los Gatos、California、美国、95032
- Women's Cancer Center - Los Gatos
-
Orange、California、美国、92868
- Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center
-
-
Colorado
-
Denver、Colorado、美国、80010
- University of Colorado Cancer Center at University of Colorado Health Sciences Center
-
-
Connecticut
-
New Haven、Connecticut、美国、06520-8028
- Yale Comprehensive Cancer Center
-
-
Delaware
-
Newark、Delaware、美国、19713
- CCOP - Christiana Care Health Services
-
-
District of Columbia
-
Washington、District of Columbia、美国、20307-5001
- Walter Reed Army Medical Center
-
-
Florida
-
Tampa、Florida、美国、33612-9497
- H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
-
-
Hawaii
-
Honolulu、Hawaii、美国、96813
- MBCCOP - Hawaii
-
-
Illinois
-
Chicago、Illinois、美国、60637-1470
- University of Chicago Cancer Research Center
-
Chicago、Illinois、美国、60612
- MBCCOP - University of Illinois at Chicago
-
Chicago、Illinois、美国、60612-3824
- Rush University Medical Center
-
Decatur、Illinois、美国、62794-9640
- CCOP - Central Illinois
-
Evanston、Illinois、美国、60201
- CCOP - Evanston
-
Urbana、Illinois、美国、61801
- CCOP - Carle Cancer Center
-
-
Indiana
-
Indianapolis、Indiana、美国、46202-5289
- Indiana University Cancer Center
-
South Bend、Indiana、美国、46617
- Saint Joseph Regional Medical Center
-
-
Iowa
-
Iowa City、Iowa、美国、52242-1002
- Holden Comprehensive Cancer Center at University of Iowa
-
-
Kentucky
-
Lexington、Kentucky、美国、40536-0084
- Markey Cancer Center at University of Kentucky Chandler Medical Center
-
-
Massachusetts
-
Boston、Massachusetts、美国、02111
- Cancer Center at Tufts - New England Medical Center
-
Worcester、Massachusetts、美国、01605-2982
- UMASS Memorial Cancer Center - University Campus
-
-
Michigan
-
Ann Arbor、Michigan、美国、48106
- CCOP - Michigan Cancer Research Consortium
-
Grand Rapids、Michigan、美国、49503
- CCOP - Grand Rapids
-
Kalamazoo、Michigan、美国、49007-3731
- CCOP - Kalamazoo
-
-
Minnesota
-
Minneapolis、Minnesota、美国、55455
- University of Minnesota Cancer Center
-
Rochester、Minnesota、美国、55905-0001
- Mayo Clinic Cancer Center
-
Saint Louis Park、Minnesota、美国、55416
- CCOP - Metro-Minnesota
-
-
Mississippi
-
Jackson、Mississippi、美国、39216-4505
- University of Mississippi Medical Center
-
Keesler AFB、Mississippi、美国、39534-2576
- Keesler Medical Center - Keesler Air Force Base
-
-
Missouri
-
Columbia、Missouri、美国、65203
- Ellis Fischel Cancer Center at University of Missouri - Columbia
-
Kansas City、Missouri、美国、64131
- CCOP - Kansas City
-
Saint Louis、Missouri、美国、63110
- Siteman Cancer Center at Barnes-Jewish Hospital
-
Springfield、Missouri、美国、65807
- CCOP - Cancer Research for the Ozarks
-
-
Nebraska
-
Omaha、Nebraska、美国、68106
- CCOP - Missouri Valley Cancer Consortium
-
-
New Jersey
-
Camden、New Jersey、美国、08103-1489
- Cancer Institute of New Jersey at the Cooper University Hospital
-
-
New York
-
Brooklyn、New York、美国、11203
- SUNY Downstate Medical Center
-
Buffalo、New York、美国、14263-0001
- Roswell Park Cancer Institute
-
Manhasset、New York、美国、11030
- North Shore University Hospital
-
New York、New York、美国、10021
- Memorial Sloan-Kettering Cancer Center
-
Stony Brook、New York、美国、11790-7775
- Long Island Cancer Center at Stony Brook University Hospital
-
-
North Carolina
-
Chapel Hill、North Carolina、美国、27599-7570
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
-
Durham、North Carolina、美国、27710
- Duke Comprehensive Cancer Center
-
Greenville、North Carolina、美国、27858
- Gynecologic Oncology Network
-
Winston-Salem、North Carolina、美国、27157-1065
- Comprehensive Cancer Center at Wake Forest University
-
-
Ohio
-
Cincinnati、Ohio、美国、45267-0520
- Charles M. Barrett Cancer Center at University Hospital
-
Cleveland、Ohio、美国、44124
- Cleveland Clinic Taussig Cancer Center
-
Cleveland、Ohio、美国、44106
- Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University
-
Columbus、Ohio、美国、43210-1240
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University
-
-
Oklahoma
-
Oklahoma City、Oklahoma、美国、73104
- University of Oklahoma College of Medicine
-
-
Oregon
-
Portland、Oregon、美国、97225
- CCOP - Columbia River Oncology Program
-
-
Pennsylvania
-
Abington、Pennsylvania、美国、19001-3788
- Abington Memorial Hospital
-
Danville、Pennsylvania、美国、17822-2001
- CCOP - Geisinger Clinic and Medical Center
-
Hershey、Pennsylvania、美国、17033-0850
- Penn State Cancer Institute at Milton S. Hershey Medical Center
-
Philadelphia、Pennsylvania、美国、19111
- Fox Chase Cancer Center
-
Philadelphia、Pennsylvania、美国、19104-4283
- Abramson Cancer Center of the University of Pennsylvania
-
Philadelphia、Pennsylvania、美国、19107
- Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
-
Pittsburgh、Pennsylvania、美国、15213-3180
- UPMC Cancer Center at Magee-Womens Hospital
-
-
Tennessee
-
Knoxville、Tennessee、美国、37917
- Southeast Gynecologic Oncology Associates
-
Nashville、Tennessee、美国、37232-2516
- Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center
-
-
Texas
-
Dallas、Texas、美国、75390-9032
- Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas
-
Galveston、Texas、美国、77555-0587
- University of Texas Medical Branch
-
Houston、Texas、美国、77030-4009
- MD Anderson Cancer Center at University of Texas
-
Temple、Texas、美国、76508
- CCOP - Scott and White Hospital
-
-
Vermont
-
Burlington、Vermont、美国、05401
- Fletcher Allen Health Care - Medical Center Hospital of Vermont Campus
-
-
Virginia
-
Charlottesville、Virginia、美国、22908
- Cancer Center at the University of Virginia
-
-
Washington
-
Seattle、Washington、美国、98109-1024
- Fred Hutchinson Cancer Research Center
-
Tacoma、Washington、美国、98405
- MultiCare Regional Cancer Center at Tacoma General Hospital
-
-
Wisconsin
-
Madison、Wisconsin、美国、53792-6188
- University of Wisconsin Comprehensive Cancer Center
-
Marshfield、Wisconsin、美国、54449
- CCOP - Marshfield Clinic Research Foundation
-
-
参与标准
资格标准
适合学习的年龄
- 孩子
- 成人
- 年长者
接受健康志愿者
有资格学习的性别
描述
DISEASE CHARACTERISTICS:
Histologically confirmed endometrial carcinoma
- Recurrent or persistent disease
- Refractory to curative or standard therapy
Measurable disease
- At least 1 unidimensionally measurable lesion ≥ 20 mm by conventional techniques OR ≥ 10 mm by spiral CT scan
At least 1 target lesion
- Tumors within a previously irradiated field are not considered target lesions
Received 1 prior chemotherapy regimen for endometrial carcinoma, including high-dose, consolidation, or extended therapy administered after surgical or non-surgical assessment
- One additional non-cytotoxic regimen for recurrent or persistent disease allowed, including monoclonal antibodies, cytokines, and small-molecule inhibitors of signal transduction
- Ineligible for a higher priority GOG protocol
PATIENT CHARACTERISTICS:
Age
- Any age
Performance status
- GOG 0-2
Life expectancy
- Not specified
Hematopoietic
- Absolute neutrophil count ≥ 1,500/mm^3
- Platelet count ≥ 100,000/mm^3
Hepatic
- SGOT ≤ 2.5 times upper limit of normal (ULN)
- Alkaline phosphatase ≤ 2.5 times ULN
- Bilirubin ≤ 1.5 times ULN
Renal
- Creatinine ≤ 1.5 times ULN
Other
- Not pregnant or nursing
- Negative pregnancy test
- Fertile patients must use effective contraception
- No neuropathy (sensory and motor) ≥ grade 2
- No active infection requiring antibiotics
- No other invasive malignancy within the past 5 years except nonmelanoma skin cancer
PRIOR CONCURRENT THERAPY:
Biologic therapy
- See Disease Characteristics
- At least 3 weeks since prior biologic or immunologic therapy for malignant tumor
- No concurrent prophylactic growth factors
- No concurrent prophylactic thrombopoietic agents
Chemotherapy
- See Disease Characteristics
- Recovered from prior chemotherapy
- No more than 1 prior cytotoxic chemotherapy regimen (single or combination cytotoxic drugs)
Endocrine therapy
- At least 1 week since prior hormonal therapy for malignant tumor
- Concurrent hormone replacement therapy allowed
Radiotherapy
- See Disease Characteristics
- Recovered from prior radiotherapy
Surgery
- Recovered from prior surgery
Other
- At least 3 weeks since other prior therapy for malignant tumor
- No prior anticancer therapy that would preclude current protocol therapy
- No concurrent amifostine or other protective reagents
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 屏蔽:无(打开标签)
合作者和调查者
调查人员
- 学习椅:Agustin Garcia, MD、Premiere Oncology
出版物和有用的链接
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.